- Trials with a EudraCT protocol (37,720)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (18,700)
37,720 result(s) found.
Displaying page 1 of 1,886.
| EudraCT Number: 2006-005520-16 | Sponsor Protocol Number: BO20603 | Start Date*: 2007-05-02 | |||||||||||
| Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
| Full Title: Ensayo clínico de fase III multicéntrico, randomizado, doble ciego, controlado con placebo, para comparar la eficacia de bevacizumab en combinación con rituximab y CHOP (RA CHOP) frente a rituxima... | |||||||||||||
| Medical condition: Pacientes con linfoma difuso de células B grandes (LDCBG) CD20-positivo no tratados previamente, que presentan enfermedad de riesgo intermedio-bajo, intermedio-alto o alto, de acuerdo con el índic... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Temporarily Halted) AT (Completed) FR (Ongoing) CZ (Ongoing) GR (Ongoing) PT (Completed) GB (Completed) SE (Completed) DE (Completed) IT (Completed) PL (Completed) SK (Ongoing) LT (Completed) HU (Ongoing) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2005-000077-22 | Sponsor Protocol Number: CL2-90652-001 | Start Date*: Information not available in EudraCT | |||||||||||
| Sponsor Name:Institut de Recherches Internationales Servier | |||||||||||||
| Full Title: Acceptability, safety, pharmacokinetics and effects on blood pressure of a daily dose of 0.025 to 0.135 milligram per kilogram of S 90652, a paediatric formulation of perindopril, in 2-16 years old... | |||||||||||||
| Medical condition: Arterial hypertension | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: BE (Completed) IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-003035-31 | Sponsor Protocol Number: KF4248/05 | Start Date*: 2005-07-06 |
| Sponsor Name:Grünenthal GmbH [...] | ||
| Full Title: Safety of the oral monophasic contraceptive GRT4248 (0.02 mg ethinylestradiol/2 mg chlormadinone acetate) in comparison to 0.02 mg ethinylestradiol/0.15 mg desogestrel given for 6 medication cycles... | ||
| Medical condition: Contraception | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: DE (Completed) IT (Completed) ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-000866-11 | Sponsor Protocol Number: 7164-L-01 | Start Date*: 2004-08-06 | |||||||||||
| Sponsor Name:ZAMBON GROUP | |||||||||||||
| Full Title: A multicenter, randomized, parallel group, controlled, double-blind study to evaluate efficacy and safety of pholcodine as antitussive agent vs dextrometorphan in non-productive cough | |||||||||||||
| Medical condition: Symptomatic treatment of non productive cough | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2004-002850-69 | Sponsor Protocol Number: IGPM01 | Start Date*: 2006-01-06 |
| Sponsor Name:Swansea NHS Trust | ||
| Full Title: Role of High dose insulin and glucose-potassium-magnesium (HDI-GKM) for Myocardial protection in cardiac surgery | ||
| Medical condition: We propose to recruit 90 patients (based on the power calculation) undergoing first time urgent in-house CABG at Morriston Hospital. The decision to operate on an urgent basis will be based on the ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-002852-33 | Sponsor Protocol Number: TOR-RIS-2004-01 | Start Date*: 2005-04-13 | |||||||||||
| Sponsor Name:Dr. Jose Vicente Torregrosa Prats (fundacio clinic) | |||||||||||||
| Full Title: a randomised, open clinical trial to study the efficacy of risedronate 35 mg/week in prevention of bone mass loss and vascular calcifications after kidney transplantation Ensayo aleatorio, abierto ... | |||||||||||||
| Medical condition: bone metabolic pathology associated to kidney transplantation | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2004-002871-18 | Sponsor Protocol Number: A-92-52030-166 | Start Date*: 2006-02-09 |
| Sponsor Name:IPSEN PHARMA, S.A. | ||
| Full Title: Phase II, open, single group,multicentre study to evaluate the efficacy and safety of Somatuline Autogel® (120 mg) administered every 4 weeks by deep subcutaneous injection in the tumour´s growth s... | ||
| Medical condition: Patients with progressive neuroendocrine tumours who are not eligible to be treated with either surgery or chemotherapy | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2004-002887-41 | Sponsor Protocol Number: OV-W05 | Start Date*: 2004-12-01 |
| Sponsor Name:OmniVision GmbH | ||
| Full Title: Randomisierte, kontrollierte, für den Prüfer verblindete klinische Prüfung (Pilotstudie) zur Untersuchung der Wirksamkeit von Spersadex® Augentropfen im Vergleich zu Isopto®-Dex Augentropfen bei Pa... | ||
| Medical condition: Nicht-infektiöse Conjunctivitis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004136-31 | Sponsor Protocol Number: EF489-2004/1 | Start Date*: 2005-07-08 |
| Sponsor Name:Laboratorios Effik, S.A. | ||
| Full Title: Ensayo clínico para evaluar la eficacia de los suplementos de progesterona natural en la prevención del parto pretérmino gemelar | ||
| Medical condition: Parto pretérmino en embarazos gemelares | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004148-34 | Sponsor Protocol Number: B9E-XM-O435 | Start Date*: 2005-02-25 |
| Sponsor Name:Dr. José Ignacio Chacón López-Muñiz | ||
| Full Title: ENSAYO EN FASE I/II DE LA COMBINACIÓN DE GEMCITABINA EN INFUSIÓN PROLONGADA Y PACLITAXEL ADMINISTRADOS DE FORMA QUINCENAL EN EL TRATAMIENTO DE PRIMERA LÍNEA DE PACIENTES CON CÁNCER DE MAMA AVANZADO | ||
| Medical condition: Cancer de mama avanzado | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004153-25 | Sponsor Protocol Number: JIA6 | Start Date*: 2004-12-10 |
| Sponsor Name:Royal Hospital For Sick Children, Yorkhill Division | ||
| Full Title: Effect of recombinant growth hormone on growth and chondrocyte dynamics in children with juvenile idiopathic arthritis (JIA) and growth failure. | ||
| Medical condition: Growth retardation secondary to juvenile idiopathic arthritis | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2004-004160-67 | Sponsor Protocol Number: Protocol F1J-MC-SBCT (a) | Start Date*: 2005-02-24 |
| Sponsor Name:Eli Lilly and Company Limited | ||
| Full Title: Effect of Duloxetine on Valsalva Leak Point Pressure and Quantitative Rhabdosphincter Electromyography Measures in Women with Stress Urinary Incontinence | ||
| Medical condition: stress urinary incontinence | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: GB (Completed) DK (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005120-13 | Sponsor Protocol Number: VR040/001 | Start Date*: 2005-12-21 |
| Sponsor Name:Vectura Group plc | ||
| Full Title: A clinic based, Phase IIa, randomised, double-blind, placebo-controlled, ascending dose, single centre study investigating the safety, tolerability, efficacy, and pharmacokinetics of VR040 in patie... | ||
| Medical condition: Hypomobility (“off” or “freezing”) episodes associated with advanced Parkinson’s disease | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2005-005146-39 | Sponsor Protocol Number: P04501 | Start Date*: 2006-09-14 | |||||||||||
| Sponsor Name:Schering Plough Research Institute | |||||||||||||
| Full Title: A Phase-2, 12-week, Double-Blind, Dose-Finding, Placebo-Controlled Study to Assess the Efficacy and Safety of a range of SCH 420814 Doses 1 mg BID, 2 mg BID, 5 mg BID and Possibly 10 mg BID in Su... | |||||||||||||
| Medical condition: Moderate to severe Parkinson s disease with motor fluctuation and dyskinesias. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2007-000381-20 | Sponsor Protocol Number: 27820 | Start Date*: 2007-11-16 | |||||||||||
| Sponsor Name:Merck Serono S.A. - Geneva | |||||||||||||
| Full Title: A Phase IIIb, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group, Extension Trial to Evaluate the Safety and Tolerability of Oral Cladribine in Subjects with Relapsing-Remitting Multiple... | |||||||||||||
| Medical condition: Relapsing Remitting Multiple Sclerosis (RRMS) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: FI (Completed) FR (Ongoing) GB (Completed) CZ (Completed) BE (Completed) EE (Completed) AT (Completed) PT (Completed) NL (Completed) DE (Completed) DK (Completed) IT (Completed) GR (Completed) LV (Completed) LT (Completed) BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-004107-20 | Sponsor Protocol Number: CAS ELF | Start Date*: 2007-10-23 |
| Sponsor Name:Medical University, Dpt. Internal Medicine, Div. of General Internal Medicine | ||
| Full Title: LUNG PENETRATION OF CASPOFUNGIN INTO EPITHELIAL LINING FLUID | ||
| Medical condition: Plasma and ELF concentrations of Caspofungin will be measured in patients requiring treatment with Cancidas (Caspofungin) for fungal infection (proven or suspected) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-003646-34 | Sponsor Protocol Number: LT-COX-2.001 | Start Date*: 2005-10-10 |
| Sponsor Name:Klaipeda hospital | ||
| Full Title: COX-2 alteration in advanced colon cancer treated with capecitabine versus 5-fluorouracil and calcium folinate (Mayo regimen) combination | ||
| Medical condition: III stage (Dukes' stage) colon cancer patients who underwent surgery | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: LT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-003648-70 | Sponsor Protocol Number: ML 19365 | Start Date*: 2007-02-08 |
| Sponsor Name:Charité Universitätsmedizin Berlin | ||
| Full Title: Randomised, double-blinded phase IIIb study to optimise antiviral therapy response of a standard therapy consisting of peginterferon-alfa-2a and ribavirin plus the additional use of bezafibrat 400 ... | ||
| Medical condition: First time treatment in chronic hepatitis C-infection patients with elevated GGT-level without coinfections as HBV, HDV and HIV | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001543-36 | Sponsor Protocol Number: 091257-2005 | Start Date*: 2006-05-15 |
| Sponsor Name:NHS Lothian | ||
| Full Title: The effects of lipoic acid on glycaemic control in type 2 diabetes. | ||
| Medical condition: Type 2 diabetes mellitus. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2005-001548-21 | Sponsor Protocol Number: ICLA-08-CSI1 | Start Date*: 2005-06-21 | |||||||||||
| Sponsor Name:Arpida AG | |||||||||||||
| Full Title: Phase 3, Randomized, Investigator-Blind, Multi-Center Study to Evaluate Efficacy and Safety of Intravenous Iclaprim versus Intravenous Linezolid in Complicated Skin and Skin Structure Infections | |||||||||||||
| Medical condition: Complicated skin and skin structure infections are predominantly caused by the following Gram-positive pathogens: Staphylococcus aureus, including methicillin-resistant strains, beta hemolytic stre... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: LV (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
